Part 1
We can observe that both Medicare reimbursement (MCR) and third party payer (TPP) are
profitable for most of the processes, MCR is not profitable for just three processes biopsy breast
1st lesion STRTCTC , biopsy breast add lesion STRTCTC and biopsy breast 1st lesion
STRTCTC, except these three processes all there process of both TPP and MCR are profitable.
Part 2
In Medicare segment maximum profit is for “PLACE BALLOON CATHETER FOR
RADIOELEMENT APP” and minimum profit is for below mentioned three processes
1. Biopsy breast 1st lesion STRTCTC ,
2. Biopsy breast add lesion STRTCTC
